NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017Mary B. Daly, Susan Darlow, Judy E. Garber et al.|Journal of the National Comprehensive Cancer Network|2016Cited by 660
Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015Mary B. Daly, Susan Darlow, Robert Pilarski et al.|Journal of the National Comprehensive Cancer Network|2016Cited by 293
Management of individuals with germline pathogenic/likely pathogenic variants in CHEK2: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)Helen Hanson, Douglas R. Stewart, Esteban Astiazarán-Symonds et al.|Genetics in Medicine|2023Cited by 79